share_log

WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K

WEED Inc. Acquires Hempirical Genetics, With Over 250 Proprietary Cannabis & Hemp Strains For $750K

威德公司以75万美元收购拥有250多种专有大麻和大麻品种的HEMPLICAL Genetics公司
Benzinga Real-time News ·  2022/07/21 08:00

WEED, Inc. (OTCQB:BUDZ) a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, acquired 100% of Hempirical Genetics, LLC, for 2 million shares of common stock valued at $.25 per share and $250,000 in cash over 4 years. One million shares and $10,000 was paid on signing this agreement.

威德公司(场外交易代码:BADZ)是一家总部位于美国的全球大麻和大麻生物研究公司,专注于开发和应用大麻衍生化合物,用于治疗人类和动物疾病。收购半经验遗传公司100%的股份,用于200万股每股价值0.25美元的普通股以及25万美元的现金四年多了。在签署这份协议时,支付了100万股和1万美元。

Glenn E. Martin, WEED, Inc.'s CEO stated, "Our teams in USA, Australia and Israel are excited that a pipeline of Original "Landrace" strains from the 1970s' can now be moved into clinical trials and product development for the global market. WEED now has over 15 "PURE" original, pristine, F-1 grade cannabis strains today, including, Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold. Our newly acquired inventory includes over 30 CBD & CBG strains as WEED believes that multiple combinations of precise cannabinoid strains will create the entourage effect to achieve the medical outcome desired. Eventually, WEED plans to bring our unique desired strains to the Adult Use markets once the "Law of the Land" brings back the Freedoms lost 70+ years ago."

格林·E·马丁我们在美国、澳大利亚和以色列的团队很兴奋,因为20世纪70年代的一批原始的长白氏菌株现在可以进入临床试验和全球市场的产品开发。威德公司现在有15个以上。纯净“原始的,原始的,F-1今天的大麻品种等级,包括,巴拿马红,阿卡普尔科金色,哥伦比亚红芽和圣玛尔塔金色。我们新获得的库存包括30多种CBD和CBG菌株,因为杂草相信,精确的大麻素菌株的多种组合将产生环境效应,以实现预期的医疗结果。最终,威德计划一旦《土地法》将70多年前失去的自由带回市场,就会将我们独特的所需品种带到成人用品市场。

Jeffery Miller, the previous owner of Hempirical Genetics, will lead the charge in strain & product development as HEMP BioScience's new CEO. Martin continued, "I've known Jeff for a half a century. His horticulture skills and dedication the Cannabaceae plant cannot be duplicated. I'm extremely proud to have my old friend and his team, (whose strains WEED bought in the acquisition), which we believe will bring year-over-year success to the benefit of WEED's shareholders."

杰弗里·米勒,以前是HEMPLICAL Genetics的所有者,将领导菌株和产品开发,作为大麻生物科学马丁继续说:“我认识杰夫有半个世纪了。他的园艺技能和对大麻植物的奉献是不可复制的。我非常自豪有我的老朋友和他的团队(他们的品系威德在收购中被收购),我们相信他们将带来年复一年的成功,让威德的股东受益。”

Miller stated, "I've known Glenn Martin for 50+ years and honored to take the helm of HEMP BioSciences to buildout our genetic studies. My goal is to bring the strongest, highest quality THC and hemp products to market at affordable prices. "Double the quality, half the price" should be the mantra for the cannabis industry, while creating diversity & equality to the cannabis sector. Our Veterans have been highly overlooked, and I look to develop vet programs at low or no cost, which I know is a priority of Glenn and mine."

米勒说:“我认识格伦·马丁50多年了,我很荣幸能执掌大麻生物科学公司,为我们的基因研究奠定基础。我的目标是以合理的价格将最强大、最高质量的THC和大麻产品推向市场。”质量加倍,价格减半“应该是大麻行业的口号,同时为大麻行业创造多样性和平等。我们的退伍军人一直被高度忽视,我希望以低成本或免费的方式发展兽医项目,我知道这是格伦和我的优先事项。”

Photo by CRYSTALWEED cannabis on Unsplash

结晶器大麻在Unspash上的照片

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发